ID ALF1_STAA1 Reviewed; 296 AA. AC A7X6Y6; DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot. DT 23-OCT-2007, sequence version 1. DT 27-MAR-2024, entry version 75. DE RecName: Full=Fructose-bisphosphate aldolase class 1 {ECO:0000255|HAMAP-Rule:MF_00729}; DE EC=4.1.2.13 {ECO:0000255|HAMAP-Rule:MF_00729}; DE AltName: Full=Fructose-bisphosphate aldolase class I; DE Short=FBP aldolase {ECO:0000255|HAMAP-Rule:MF_00729}; GN Name=fda {ECO:0000255|HAMAP-Rule:MF_00729}; GN OrderedLocusNames=SAHV_2590; OS Staphylococcus aureus (strain Mu3 / ATCC 700698). OC Bacteria; Bacillota; Bacilli; Bacillales; Staphylococcaceae; OC Staphylococcus. OX NCBI_TaxID=418127; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Mu3 / ATCC 700698; RX PubMed=17954695; DOI=10.1128/aac.00534-07; RA Neoh H.-M., Cui L., Yuzawa H., Takeuchi F., Matsuo M., Hiramatsu K.; RT "Mutated response regulator graR is responsible for phenotypic conversion RT of Staphylococcus aureus from heterogeneous vancomycin-intermediate RT resistance to vancomycin-intermediate resistance."; RL Antimicrob. Agents Chemother. 52:45-53(2008). CC -!- CATALYTIC ACTIVITY: CC Reaction=beta-D-fructose 1,6-bisphosphate = D-glyceraldehyde 3- CC phosphate + dihydroxyacetone phosphate; Xref=Rhea:RHEA:14729, CC ChEBI:CHEBI:32966, ChEBI:CHEBI:57642, ChEBI:CHEBI:59776; EC=4.1.2.13; CC Evidence={ECO:0000255|HAMAP-Rule:MF_00729}; CC -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3- CC phosphate and glycerone phosphate from D-glucose: step 4/4. CC {ECO:0000255|HAMAP-Rule:MF_00729}. CC -!- SIMILARITY: Belongs to the class I fructose-bisphosphate aldolase CC family. {ECO:0000255|HAMAP-Rule:MF_00729}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AP009324; BAF79473.1; -; Genomic_DNA. DR RefSeq; WP_001031409.1; NC_009782.1. DR AlphaFoldDB; A7X6Y6; -. DR SMR; A7X6Y6; -. DR KEGG; saw:SAHV_2590; -. DR HOGENOM; CLU_081560_0_0_9; -. DR UniPathway; UPA00109; UER00183. DR GO; GO:0004332; F:fructose-bisphosphate aldolase activity; IEA:UniProtKB-UniRule. DR GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-UniRule. DR Gene3D; 3.20.20.70; Aldolase class I; 1. DR HAMAP; MF_00729; FBP_aldolase_1; 1. DR InterPro; IPR013785; Aldolase_TIM. DR InterPro; IPR000741; FBA_I. DR InterPro; IPR023014; FBA_I_Gram+-type. DR PANTHER; PTHR11627; FRUCTOSE-BISPHOSPHATE ALDOLASE; 1. DR PANTHER; PTHR11627:SF80; FRUCTOSE-BISPHOSPHATE ALDOLASE; 1. DR Pfam; PF00274; Glycolytic; 1. DR SUPFAM; SSF51569; Aldolase; 1. PE 3: Inferred from homology; KW Glycolysis; Lyase; Schiff base. FT CHAIN 1..296 FT /note="Fructose-bisphosphate aldolase class 1" FT /id="PRO_1000045916" FT ACT_SITE 175 FT /note="Proton acceptor" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00729" FT ACT_SITE 212 FT /note="Schiff-base intermediate with dihydroxyacetone-P" FT /evidence="ECO:0000255|HAMAP-Rule:MF_00729" SQ SEQUENCE 296 AA; 33042 MW; D63B1A3C7646725B CRC64; MNKEQLEKMK NGKGFIAALD QSGGSTPKAL KEYGVNEDQY SNEDEMFQLV HDMRTRVVTS PSFSPDKILG AILFEQTMDR EVEGKYTADY LADKGVVPFL KVDKGLAEEQ NGVQLMKPID NLDSLLDRAN ERHIFGTKMR SNILELNEQG IKDVVEQQFE VAKQIIAKGL VPIIEPEVNI NAKDKAEIEK VLKAELKKGL DSLNADQLVM LKLTIPTEPN LYKELAEHPN VVRVVVLSGG YSREKANELL KDNDELIASF SRALASDLRA DQSKEEFDKA LGDAVESIYD ASVNKN //